95 related articles for article (PubMed ID: 19019865)
1. POPADAD trial. Time for a proper study of aspirin after a vascular event?
Cleland JG
BMJ; 2008 Nov; 337():a2583. PubMed ID: 19019865
[No Abstract] [Full Text] [Related]
2. POPADAD trial. Don't stop taking aspirin.
Elwood P
BMJ; 2008 Nov; 337():a2581. PubMed ID: 19019864
[No Abstract] [Full Text] [Related]
3. [Antiplatelet and anticoagulant treatment after percutaneous transluminal angioplasty for peripheral arteriosclerosis. Survey of a Cochrane review].
Lorenzen ND; Eldrup N; Laustsen J
Ugeskr Laeger; 2007 Sep; 169(39):3279-82. PubMed ID: 17953885
[No Abstract] [Full Text] [Related]
4. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.
Belch J; MacCuish A; Campbell I; Cobbe S; Taylor R; Prescott R; Lee R; Bancroft J; MacEwan S; Shepherd J; Macfarlane P; Morris A; Jung R; Kelly C; Connacher A; Peden N; Jamieson A; Matthews D; Leese G; McKnight J; O'Brien I; Semple C; Petrie J; Gordon D; Pringle S; MacWalter R; ; ;
BMJ; 2008 Oct; 337():a1840. PubMed ID: 18927173
[TBL] [Abstract][Full Text] [Related]
5. Aspirin for primary prevention of cardiovascular disease?
Drug Ther Bull; 2009 Nov; 47(11):122-5. PubMed ID: 19887685
[TBL] [Abstract][Full Text] [Related]
6. Picotamide versus aspirin in diabetic patients with peripheral arterial disease: has David defeated Goliath?
Gresele P; Migliacci R
Eur Heart J; 2004 Oct; 25(20):1769-71. PubMed ID: 15474690
[No Abstract] [Full Text] [Related]
7. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?
Wienbergen H; Senges J; Gitt AK
Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489
[No Abstract] [Full Text] [Related]
8. Taking cardiovascular risk factors to heart.
Clark WL
Diabetes Self Manag; 2002; 19(6):60-2, 64. PubMed ID: 12561770
[No Abstract] [Full Text] [Related]
9. Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
Price HC; Holman RR
Nat Clin Pract Cardiovasc Med; 2009 Mar; 6(3):168-9. PubMed ID: 19153560
[TBL] [Abstract][Full Text] [Related]
10. CAPRIE trial.
Violi F
Lancet; 1997 Feb; 349(9048):354; author reply 356. PubMed ID: 9024393
[No Abstract] [Full Text] [Related]
11. Effect of naftidrofuryl on platelet aggregation in plasma from aspirin treated patients: an in vitro study.
Le Dévéhat C; Khodabandehlou T; Mosnier M
Clin Hemorheol Microcirc; 2000; 22(3):197-204. PubMed ID: 10976713
[TBL] [Abstract][Full Text] [Related]
12. [Should one prescribe aspirin for all diabetics?].
Passa P
Diabetes Metab; 1997 Dec; 23(6):554-6. PubMed ID: 9496565
[No Abstract] [Full Text] [Related]
13. Antiplatelet drugs in cardiovascular diseases.
Weston C; Rao U
Int J Clin Pract; 2003 Dec; 57(10):898-905. PubMed ID: 14712893
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet agents in the prevention of diabetic vascular complications.
Patrono C; Daví G
Diabetes Metab Rev; 1993 Oct; 9(3):177-88. PubMed ID: 8187606
[No Abstract] [Full Text] [Related]
15. Aspirin: not currently for primary prevention in diabetes.
Jackson G
Int J Clin Pract; 2009 Jun; 63(6):831-2. PubMed ID: 19490189
[No Abstract] [Full Text] [Related]
16. Aspirin therapy in diabetes mellitus.
Colwell JA
Diabetologia; 1997 Jul; 40(7):867. PubMed ID: 9243111
[No Abstract] [Full Text] [Related]
17. Primary vascular prevention: The end of the road for aspirin?
Ajjan RA
Diab Vasc Dis Res; 2018 Nov; 15(6):475-476. PubMed ID: 30415566
[No Abstract] [Full Text] [Related]
18. Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis.
Zhang C; Sun A; Zhang P; Wu C; Zhang S; Fu M; Wang K; Zou Y; Ge J
Diabetes Res Clin Pract; 2010 Feb; 87(2):211-8. PubMed ID: 19853947
[TBL] [Abstract][Full Text] [Related]
19. [Myocardial infarct, stroke and vascular events reduced by a third].
Z Kardiol; 1997 Nov; 86(11 Suppl Myokardinf):1-3. PubMed ID: 9437253
[No Abstract] [Full Text] [Related]
20. [Therapeutic use of acetylsalicylic acid in diabetics].
Zácková V
Vnitr Lek; 2003 Dec; 49(12):972-5. PubMed ID: 15040166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
